Europes generic drug industry is shifting: The generic-pharmaceutical market in Europe is undergoing major disruptions that make it imperative for both generics companies and originators to adapt. Four Powerful Forces Shake Up the Market Key segments of the generics industry are becoming commoditized amid challenges such as pricing pressures and effective defensive strategies from originator drug companies. Different Impacts for Different Segments By 2020, 70 percent of industry profits will be generated by more differentiated generics. Standard generics will continue to account for the bulk of industry volume, but they will produce a dwindling share of profits. Lessons for Surviving—and Thriving Both generics and originator companies in Europe can enhance competitiveness and transform their business models by learning from other commoditized markets. https://bcgperspectives/Images/Transforming_Europes_Generics_Industry_May_2014.pdf
Posted on: Mon, 13 Oct 2014 04:00:16 +0000
Trending Topics
Recently Viewed Topics
© 2015